Product Program year 2025 Source: CMS Open Payments

Optiflux

Device Dialyzer, Capillary, Hollow Fiber

PDI 00840861100156

Open in the dashboard

General payments

$5,649

113 payments

Research payments

$0

0 payments

Through program year 2025, $5,649 in general payments and $0 in research payments were reported against Optiflux (Dialyzer, Capillary, Hollow Fiber).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $2,648 55
2024 General $1,933 32
2023 General $36 1
2022 General $739 13
2021 General $294 12

Breakdown

Who paid General payments · program years 2021–2025
  1. Fresenius USA Marketing, Inc. $3,730 82 payments
  2. NxStage Medical, Inc. $1,919 31 payments
Top recipients General payments · program year 2025
  1. Taryn Turner Nephrology · Granbury, TX $169 6% · 3 payments
  2. Anand Reddy Nephrology · Odessa, TX $155 6% · 1 payment
  3. Tiffany Vaught Nurse Practitioner, Family · Odessa, TX $155 6% · 1 payment
  4. Joshua Lowentritt Nephrology · New Orleans, LA $147 6% · 3 payments
  5. Jeffrey Goodman Nephrology · Florham Park, NJ $118 4% · 2 payments

The top 5 of 44 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Nephrology Internal Medicine $2,266 86% · 34 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $194 7% · 3 practitioners
  3. Nurse Practitioner, Acute Care Nurse Practitioner $65 2% · 1 practitioner
  4. Internal Medicine $61 2% · 3 practitioners
  5. Nurse Practitioner $42 2% · 2 practitioners

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $713 27% · 12 recipients
  2. Louisiana $581 22% · 7 recipients
  3. Arkansas $295 11% · 3 recipients
  4. Alabama $139 5% · 2 recipients
  5. Maryland $118 4% · 1 recipient

The top 5 of 17 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

113 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record